1 story in the last 7 days
The latest splisense news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks splisense across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
SpliSense raised up to $13 million in funding. The company secured the capital to advance its pipeline of RNA-based therapies. SpliSense focuses on developing treatments for cystic fibrosis and other genetic lung diseases.
Summaries by ByteBrief